b)

ierakstus, kas attiecas uz indeksa numuriem 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 un 616-207-00-X, attiecīgi aizstāj ar šādiem: Indeksa Nr. Starptautiskā ķīmiskā identifikācija EK Nr. CAS Nr. Klasifikācija Marķējums Specifiskās robežkoncentrācijas, reizināšanas koeficients Piezīmes Bīstamības klases un kategorijas kodi Bīstamības apzīmējuma kodi Piktogramma, signālvārda kodi Bīstamības apzīmējuma kodi Papildu bīstamības apzīmējuma kodi “006-035-00-8 pirimikarbs (ISO); 2-(dimetilamino)-5,6-dimetilpirimidīn-4-ila dimetilkarbamāts 245-430-1 23103-98-2 Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H331 H301 H317 H400 H410 GHS08 GHS06 GHS09 Dgr H351 H331 H301 H317 H410 M = 10 M = 100” “029-002-00-X divara oksīds; vara (I) oksīds 215-270-7 1317-39-1 Acute Tox. 4 Acute Tox. 4 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H332 H302 H318 H400 H410 GHS07 GHS05 GHS09 Dgr H332 H302 H318 H410 M = 100” “602-020-00-0 1,2-dihlorpropāns; propilēndihlorīds 201-152-2 78-87-5 Flam. Liq. 2 Carc. 1B Acute Tox. 4* Acute Tox. 4* H225 H350 H332 H302 GHS02 GHS08 GHS07 Dgr H225 H350 H332 H302” “602-033-00-1 hlorbenzols 203-628-5 108-90-7 Flam. Liq. 3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 2 H226 H332 H315 H411 GHS02 GHS07 GHS09 Wng H226 H332 H315 H411” “603-055-00-4 propilēnoksīds; 1,2-epoksipropāns; metiloksirāns 200-879-2 75-56-9 Flam. Liq. 1 Carc. 1B Muta. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 4 STOT SE 3 Eye Irrit. 2 H224 H350 H340 H331 H311 H302 H335 H319 GHS02 GHS08 GHS06 Dgr H224 H350 H340 H331 H311 H302 H335 H319” “604-030-00-0 bisfenols A; 4,4′-izopropilidēndifenols 201-245-8 80-05-7 Repr. 1B STOT SE 3 Eye Dam. 1 Skin Sens. 1 H360F H335 H318 H317 GHS08 GHS05 GHS07 Dgr H360F H335 H318 H317” “604-092-00-9 fenols, dodecil-, sazarotas virknes; [1] fenols, 2-dodecil-, sazarotas virknes; [2] fenols, 3-dodecil-, sazarotas virknes; [3] fenols, 4-dodecil-, sazarotas virknes; [4] fenols, (tetrapropenil) atvasinājumi [5] 310-154-3 [1] [2] [3] [4] [5] 121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5] Repr. 1B Skin Corr. 1C Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H360F H314 H318 H400 H410 GHS08 GHS05 GHS09 Dgr H360F H314 H410 M = 10 M = 10” “605-013-00-0 hloraloze (INN); (R)-1,2-O-(2,2,2-trihloretilidēns)-α-D-glikofuranoze; glikohloraloze; anhidroglikohlorāls 240-016-7 15879-93-3 Acute Tox. 4* Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H336 H400 H410 GHS06 GHS09 Dgr H332 H301 H336 H410 M = 10 M = 10 C” “605-022-00-X glutarāls; glutāraldehīds; 1,5-pentāndiāls 203-856-5 111-30-8 Acute Tox. 2 Acute Tox. 3 STOT SE 3 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 A Aquatic Acute 1 Aquatic Chronic 2 H330 H301 H335 H314 H334 H317 H400 H411 GHS06 GHS05 GHS08 GHS09 Dgr H330 H301 H335 H314 H334 H317 H410 EUH071 STOT SE 3; H335: 0,5 % ≤ C < 5 % M = 1” “606-014-00-9 hlorfacinons (ISO); 2-[(4-hlorfenil)(fenil)acetil]-1H-indēn-1,3(2H)-dions 223-003-0 3691-35-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (asinis) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (asinis) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 0,1 % STOT RE 2; H373 (asinis): 0,01 % ≤ C < 0,1 % M = 1 M = 1” “606-021-00-7 N-metil-2-pirolidons; 1-metil-2-pirolidons 212-828-1 872-50-4 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 H360D*** H335 H315 H319 GHS08 GHS07 Dgr H360D*** H335 H315 H319 STOT SE 3; H335: C ≥ 10 %” “607-056-00-0 varfarīns (ISO) 4-hidroksi-3-(3-okso-1-fenilbutil)-2H-hromēn-2-ons; [1] (S)-4-hidroksi-3-(3-okso-1-fenilbutil)-2-benzpirons; [2] (R)-4-hidroksi-3-(3-okso-1-fenilbutil)-2-benzpirons [3] 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] Repr. 1 A Acute Tox. 1 Acute Tox. 1 Acute Tox. 2 STOT RE 1 Aquatic Chronic 2 H360D H330 H310 H300 H372 (asinis) H411 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (asinis) H411 Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 0,5 % STOT RE 2; H373 (asinis): 0,05 % ≤ C < 0,5 %” “607-059-00-7 kumatetralils (ISO); 4-hidroksi-3-(1,2,3,4-tetrahidro-1-naftil)kumarīns 227-424-0 5836-29-3 Repr. 1B Acute Tox. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Aquatic Chronic 1 H360D H330 H311 H300 H372 (asinis) H410 GHS08 GHS06 GHS09 Dgr H360D H330 H311 H300 H372 (asinis) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 1,0 % STOT RE 2; H373 (asinis) 0,1 % ≤ C < 1,0 % M = 10” “607-157-00-X difenakums (ISO); 3-(3-bifenil-4-il-1,2,3,4-tetrahidro-1-naftil)-4-hidroksikumarīns 259-978-4 56073-07-5 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (asinis) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (asinis) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 0,02 % STOT RE 2; H373 (asinis): 0,002 % ≤ C < 0,02 % M = 10 M = 10” “607-172-00-1 brodifakums (ISO); 4-hidroksi-3-(3-(4′-brom-4-bifenilil)-1,2,3,4-tetrahidro-1-naftil)kumarīns 259-980-5 56073-10-0 Repr. 1 A Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (asinis) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (asinis) H410 Repr. 1 A; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 0,02 % STOT RE 2; H373 (asinis): 0,002 % ≤ C < 0,02 % M = 10 M = 10” “607-375-00-5 flokumafēns (ISO); cis-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluormetilbenziloksi)fenil)-1-naftil)kumarīna un trans-4-hidroksi-3-(1,2,3,4-tetrahidro-3-(4-(4-trifluormetilbenziloksi)fenil)-1-naftil)kumarīna reakcijas masa 421-960-0 90035-08-8 Repr. 1B Acute Tox. 1 Acute Tox. 1 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H330 H310 H300 H372 (asinis) H400 H410 GHS08 GHS06 GHS09 Dgr H360D H330 H310 H300 H372 (asinis) H410 Repr. 1B; H360D: C ≥ 0,003 % STOT RE 1; H372 (asinis): C ≥ 0,05 % STOT RE 2; H373 (asinis): 0,005 % ≤ C < 0,05 % M = 10 M = 10” “607-623-00-2 diizobutilftalāts 201-553-2 84-69-5 Repr. 1B H360Df GHS08 Dgr H360Df” “613-166-00-X flumioksazīns (ISO); 2-[7-fluor-3-okso-4-(prop-2-īn-1-il)-3,4-dihidro-2H-1,4-benzoksazīn-6-il]-4,5,6,7-tetrahidro-1H-izoindol-1,3(2H)-dions — 103361-09-7 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410 M = 1 000 M = 1 000 ” “613-121-00-4 hlorsulfurons (ISO); 2-hlor-N-[[(4-metoksi-6-metil-1,3,5-triazīn-2-il)amino]karbonil]benzolsulfonamīds 265-268-5 64902-72-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 000 M = 100” “616-011-00-4 N,N-dimetilacetamīds 204-826-4 127-19-5 Repr. 1B Acute Tox. 4* Acute Tox. 4* H360D*** H332 H312 GHS08 GHS07 Dgr H360D*** H332 H312” “616-037-00-6 acetohlors (ISO); 2-hlor-N-(etoksimetil)-N-(2-etil-6-metilfenil)acetamīds 251-899-3 34256-82-1 Carc. 2 Repr. 2 Acute Tox. 4 STOT SE 3 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H361f H332 H335 H373 (nieres) H315 H317 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361f H332 H335 H373 (nieres) H315 H317 H410 M = 1 000 M = 100” “616-207-00-X poliheksametilēnbiguanīda hidrohlorīds; PHMB — 32289-58-0 27083-27-8 Carc. 2 Acute Tox. 2 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 H351 H330 H302 H372 (elpceļi) (ieelpošana) H318 H317 H400 H410 GHS08 GHS06 GHS05 GHS09 Dgr H351 H330 H302 H372 (elpceļi) (ieelpošana) H318 H317 H410 M = 10 M = 10”